Asset

Varegacestat

Immunome Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (1)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT04871282phase2_3active_not_recruiting2021-09-012025-12-03Immunome, Inc.A Study of AL102 in Patients With Progressing Desmoid Tumors

FDA applications (0)

This company has no applications containing this asset.

Marketed products (0)